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Abstract
Microbial exposures in homes of asthmatic adults have been rarely investigated; spe-
cificities and implications for respiratory health are not well understood. The objec-
tives of this study were to investigate associations of microbial levels with asthma 
status, asthma symptoms, bronchial hyperresponsiveness (BHR), and atopy. Mattress 
dust samples of 199 asthmatics and 198 control subjects from 7 European countries 
participating in the European Community Respiratory Health Survey II study were 
analyzed for fungal and bacterial cell wall components and individual taxa. We ob-
served trends for protective associations of higher levels of mostly bacterial markers. 
Increased levels of muramic acid, a cell wall component predominant in Gram- positive 
bacteria, tended to be inversely associated with asthma (OR’s for different quartiles: II 
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1  | INTRODUCTION
Exposure to environmental microbes may impact on human health 
both harmfully and beneficially. Mold and dampness at home have 
been associated with respiratory symptoms and asthma in adults and 
children1-4, and microbial exposures are believed to play a key role 
in these observations. A recent review has concluded on a causal re-
lationship between indoor dampness and mold and asthma exacer-
bation.3 On the other hand, contacting certain microbial exposures 
in early life has been reported to protect from the development of 
asthma and allergy.5,6 Endotoxin as a part of the Gram- negative bacte-
rial cell wall has been shown to protect from developing asthma and 
atopy in some studies.7,8 Richness of different fungal species in house 
dust9-11 as well as certain microbial taxa has shown similar protec-
tive associations.9,12 The majority of studies on house dust microbiota 
and asthma and allergy target children and study the development of 
asthma; characteristics of house dust microbiota and asthma status in 
adults has been less explored.
European Community Respiratory Health Survey (ECRHS) is a large 
European adult population study investigating risk factors of asthma.13 
In the follow- up study, ECRHS II, a subsample of the homes, was in-
vestigated for visible mold and dampness and mattress dust samples 
were collected from the occupants’ beds. Earlier analyses within the 
ECRHS have found positive associations between indoor molds and 
dampness and health outcomes, for example, visible mold with asthma 
symptoms and bronchial responsiveness,14 and visible mold and water 
damage with new asthma cases.15 These findings are in line with a 
good body of literature that suggests an adverse effect of exposure to 
indoor dampness and mold on occupants’ respiratory health via bio-
logical indoor pollution, but the causal connections and pathophysio-
logical mechanisms are still unclear.4,16
As part of the HITEA project (Health effects of indoor pollutants: 
Integrating microbial, toxicological and epidemiological approaches), 
the aim of this study was to provide a detailed description of mea-
surements of microbial exposures in homes of asthmatic and non- 
asthmatic adults. This is the most extensive asthma case- control 
study to- date with respect to quantitatively measuring a large rep-
ertoire of fungal and bacterial cell wall markers and more specific 
microbial species and groups in dust using DNA- based and chemical 
approaches.
2  | MATERIALS AND METHODS
2.1 | Study design
The ECRHS started as a multicenter cross- sectional study to estimate 
variations in the prevalence of asthma, asthma- like symptoms, airway 
responsiveness, and allergy and their risk factors in adults living in 
Europe.17 A part of the participants was followed up as and examined 
at ECRHS II, where 22 centers agreed to take part in a detailed as-
sessment of home exposures, including collecting dust samples from 
mattress. The full protocols of this research are described at webpage 
http://www.ecrhs.org.
For this current study, a specific population was chosen from 
ECRHS II participants with frequency matching for center at 14 study 
centers located in different climatic regions in Europe based on a case- 
control design; 200 asthmatics and 200 center- matched controls were 
selected. Mattress dust samples from 199 asthmatics and 198 control 
subjects were analyzed for microbial content, as 3 samples had missing 
data. The centers, number of participants from each center, and gen-
eral information of the study subjects are listed in Table 1.
2.2 | Asthma
The selection of subjects with current asthma was based on the fol-
lowing criteria at ECRHS II: positive answers to asthma ever and 
0.71 [0.39- 1.30], III 0.44 [0.23- 0.82], and IV 0.60 [0.31- 1.18] P for trend .07) and with 
asthma score (P for trend .06) and with atopy (P for trend .02). These associations were 
more pronounced in northern Europe. This study among adults across Europe supports 
a potential protective effect of Gram- positive bacteria in mattress dust and points out 
that this may be more pronounced in areas where microbial exposure levels are gener-
ally lower.
K E Y W O R D S
asthma, atopy, bacteria, fungi, microbial exposure
PRACTICAL IMPLICATIONS
• Investigating indoor microbial exposure in homes of asth-
matic and non-asthmatic adults in different European 
countries, we observe beneficial effects of higher bacte-
rial, but not fungal levels in mattress dust, specifically of 
muramic acid, which is a cell wall component predomi-
nant in Gram-positive bacteria. Effects of exposure to 
microbes on asthma and atopy may be different for dif-
ferent geographic regions and exposure to the “right” in-
door microbiota may be particularly beneficial in areas 
where microbial levels are overall lower.
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physician diagnosed asthma, as well as at least 1 positive answer to 
questions on asthma symptoms (“wheeze” or “chest tightness” or “at-
tacks of breathlessness following activity or at rest” or “asthma attack” 
or “current medication” or “woken by attack of shortness of breath”) 
or treatment in the past 12 months. Controls were defined as sub-
jects, with negative answers to all above questions.
2.3 | Asthma score
The asthma score was used as semi- quantitative measure. The asthma 
score was calculated based on report of asthma symptoms in the past 
12 months.18 The ordinal score, ranges from 0 to 5, based on positive 
answers to questions on wheeze with breathlessness, chest tightness, 
attacks of shortness of breath at rest, shortness of breath after exer-
cise, and being woken by shortness of breath.
2.4 | Atopy
Blood samples were taken during ECRHS II for measurement of serum 
immunoglobulin E (IgE). Specific IgE to house dust- mite, timothy grass, 
cat, and Cladosporium, as well as total IgE, were measured using the 
Pharmacia CAP System (Pharmacia Diagnostics, Uppsala, Sweden). 
Atopy was defined as at least 1 specific IgE level > 0.35 kU/L.19
2.5 | Bronchial hyper- responsiveness
Bronchial hyper- responsiveness (BHR) was defined as a fall of forced 
expiratory volume (FEV1) after methacholine inhalation as described 
previously.20 Provocation was stopped when FEV1 had dropped by 
20% or after a maximum cumulative dose of 2.0 mg of methacho-
line. The methacholine challenge was carried out using Mefar MB3 
dosimeter (Mefar srl, Bovezzo, Italy). The dose- response “slope” 
(transformed log slope) was calculated and considered as an index of 
responsiveness,21 where a steep “slope” (low numeric value) is indica-
tive of a high BHR.
2.6 | Dust samples
Mattress dust samples were collected during home visits in ECRHS II as 
described earlier.22 Shortly, a template of 80 cm × 125 cm was placed 
on the area of the bed where the participant usually slept. An ALK dust 
collection filter (ALK- Abello, Hørsholm, Denmark) was attached to an 
Electrolux Mondo vacuum cleaner (1300 W), and the area within the 
template (1 m2) was vacuumed for 2 minutes. The dust was stored fro-
zen at - 20°C until processing in 2008 at Imperial College. Dust was 
sieved to remove larger particles, aliquoted into subsamples, weighted, 
and stored at −20°C. A dust aliquot was shipped on dry- ice to the 
analyzing laboratory at the National Institute for Health and Welfare, 
Kuopio, Finland, in late 2008. There, the samples were weighed in 3 ali-
quots of 5- 20 mg for the different laboratory analyses: qPCR analyses, 
ergosterol, muramic acid, and 3- hydroxy fatty acids (3- OHFA).
2.7 | DNA- extraction
DNA was extracted from the 20 mg dust samples as described ear-
lier23,24 using bead- beating and GenElute™ Plant genomic DNA mini-
prep kit (Sigma Aldrich, Saint Louis, MO, USA). Geotrichum candidum 
(EPA 400) was added to the samples at the beginning of the extraction 
and used as an internal standard.
2.8 | qPCR
To quantitatively measure the concentration of certain microbial 
groups or species in the dust samples, 9 qPCR assays were run on the 
TABLE  1 Characteristics of the study population by cases and 
controls and numbers of study subjects per study center
Cases (N = 198)
Controls 
(N = 199)
Parental allergy (%) 46.0 35.2
Smoking status (%)
Lifetime non- smoker 42.4 41.7
Ex- smoker 35.4 41.2
Current smoker 22.2 17.1
Atopy (%) 63.3 17.8
BHR slope (%)
6.01< 59.2 13.5
6.02- 8.24 24.2 40.4
>8.25 16.7 46.2
Household density (%)
<0.75 people per room 47.7 49.2
Male (%) 47.0 47.7
Age
<38.8 28.3 22.1
38.8- 45.0 22.7 27.2
45.1- 49.9 24.8 25.1
>49.9 24.2 25.6
No of subjects per center
Hamburg (Germany) 11 11
Erfurt (Germany) 13 13
Barcelona (Spain) 15 15
Galdakao (Spain) 14 14
Albacete (Spain) 15 15
Oviedo (Spain) 15 15
Grenoble (France) 14 14
Ipswich (UK) 15 15
Norwich (UK) 14 15
Reykjavik (Iceland) 15 14
Gothenburg (Sweden) 15 15
Umea (Sweden) 14 14
Uppsala (Sweden) 13 14
Basel (Switzerland) 15 15
Total 198 199
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samples. The assays targeted fungal as well as bacterial taxa and were 
specific for 1 species (Alternaria alternata, A. versicolor, Cladosporium 
cladosporioides, Cladosporium herbarum, Cladosporium sphaerosper-
mum), several species of 1 genus (Trichoderma viride/atroviride/kon-
ingii), 1 genus (Mycobacterium spp., Streptomyces spp.), or several 
genera (group of Penicillium/Aspergillus/Paecilomyces variotii; later on 
called as “group of Pen/Asp”). The used qPCR primers and probes 
have been published earlier.24-27 Detection limits for the qPCR varied 
between <1 and 350 cells depending on the assay. The qPCR labo-
ratory analyses, use of internal standard, and calculations were per-
formed as described by Kaarakainen et al,28 using the ABI Prism 7000 
(Applied Biosystems, Foster City, CA, USA) and the RotorGene 3000 
(Corbett Life Science, Mortlake, Australia) equipment.
2.9 | Cell wall markers of microbes
Two aliquots of about 5 mg of dust were used for the determination 
of chemical markers: 1 for ergosterol and another for 3- hydroxy fatty 
acids (3- OHFA) and muramic acid. The sample preparations of ergos-
terol and 3- OHFAs were carried out by slightly modifying the method 
presented by Sebastian and Larsson29 and the preparation of muramic 
acid by modifying the method presented by Sebastian et al30 In our 
method, hexane was used instead of heptane. The ergosterol and mu-
ramic acid samples were diluted to 100 mL of hexane and to 150 mL 
of chloroform, respectively, before analysis by gas chromatography 
tandem mass spectrometry (GC–MS–MS). In the preparation of 3- 
OHFAs, no water was used in the first extraction. The analyses of 
ergosterol and muramic acid were performed with a PolarisQ ion trap 
mass spectrometer (MS–MS) from Thermo (Austin, TX, USA) equipped 
with a Trace GC- ultra gas chromatograph (GC) from (Milan, Italy) with 
a DB- 5MS fused silica capillary column from J&W Scientific (Folsom, 
CA, USA). Detection limits for the chemical markers were between 1.0 
and 5.4 ng/sample. Lipopolysaccharide (LPS) amount was calculated 
as the sum of 10- 16 chain length 3- OHFA’s divided by 4, based on the 
knowledge that 4 mol of 3- OHFA’s corresponded to 1 mole of LPS, as 
described earlier.31
2.10 | Statistical analyses
Statistical analyses were performed using SAS (version 9.2, SAS 
Institute Inc., Cary, NC, USA) and with the SPSS statistical (22.0.).
Microbial data were categorized into either quartiles or tertiles 
if there were many values below detection limit: first tertile below 
detection limit, second below the median of detectable values, and 
third above the median of detectable values. Additionally, microbial 
data were presented as interquartile range (IQR) for the analyses with 
health outcomes. Zero was used for non- detects for all data.
A “total microbial content” variable was built as follows: each single 
microbial cell wall marker (MuAc, LPS, and ergosterol) was first divided 
into 5 groups using quintiles as cutoffs. Quintiles got values 0, 1, 2, 
3, and 4 from lowest to highest. Finally, values from all markers were 
summed to get a score ranging from 0 to 12. These score values were 
used in statistical analyses as a variable “Sum (MuAC, LPS, Ergosterol).”
For the geographic variation analyses, study subjects were classi-
fied into 3 climatic areas: North Europe (N = 115, including subjects 
from Reykjavik, Göteborg, Umea, Uppsala centres), central Europe 
(N = 166, including subjects from Hamburg, Erfurt, Grenoble, Ipswich, 
Norwich, Basel centres), and South Europe (N = 119, including sub-
jects from Barcelona, Galdakao, Albacete, Oviedo centres).
Weighted logistic regression analyses and weighted regression 
analyses were used to investigate associations between the cate-
gorized microbial parameters and health outcomes. Analyses for all 
health outcomes other than asthma were weighted. Weights were 
calculated based on the asthma case status and center. Trend test 
analysis was used to investigate monotonic order of the categorized 
microbial groups and their associations with health outcomes. The 
association between the health outcomes and the log- transformed 
concentrations of microbial markers was assessed using mixed neg-
ative binomial regression analysis. To allow for log- transformation of 
datasets with zero values, we used ln(value+1). All models were ad-
justed for parental allergy, smoking status, household density, gender, 
age, and center. Confounders were selected a priori based on previous 
studies. Correlations between microbial parameters were analyzed 
using Spearman’s rho correlation coefficients. Interactions of microbial 
markers with geographic area for analyses on asthma were also tested.
3  | RESULTS
We observed fairly large variations of the different microbial exposures 
in study centers across Europe (up to 25- fold differences between me-
dians for qPCR markers and up to 4- fold differences for cell wall mark-
ers between centers; Table S1). There was no clear common geographic 
trend for North, Central, and South Europe that would apply consistently 
for all microbial parameters (Figure 1). Prevalence and levels of the indi-
vidual microbial parameters are presented in Table 2. Determinations of 
cell wall components of bacteria (muramic acid, LPS) and fungi (ergos-
terol) as well as most of the qPCR assays of microbial genera or groups 
returned values above detection limits for all or most of the samples, 
while some of the species- specific qPCR assays (Alternaria alternata, 
A. versicolor, Trichoderma viride/atroviride/koningii) led to high numbers of 
results below detection limit (65%- 88%; Table 2).
Correlations between the microbial parameters are presented 
in Table 3. Correlations were mostly low, with Spearman correlation 
coefficients rarely exceeding 0.3. Good correlations were observed 
between the Cladosporium species C. herbarum and C. cladosporioides. 
Significant correlations were observed within a cluster constituted by 
C. herbarum, C. cladosporioides, A. alternata, and the bacterial genera 
Mycobacterium spp., and Streptomyces spp., with correlation coeffi-
cients ranging from 0.32 to 0.72.
3.1 | Microbial parameters and asthma, asthma 
score, and BHR
Considering general cell wall markers of microbial exposure in the 
whole study population, we observed inverse (protective) associations 
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of the bacterial muramic acid and total microbial content (sum of mu-
ramic acid, LPS, and ergosterol) in mattress dust with asthma (Table 4). 
Inverse associations were borderline significant for muramic acid 
(middle group; trend test P- value .07), and this was consistent with 
findings for the asthma score (borderline significant, P = .06; Table 5), 
but not with BHR (Table 4). Adding other cell wall markers (LPS and 
F IGURE  1 Levels of log- transformed microbial markers in dust samples of the ECRHS II with study centers categorized into 3 geographic 
areas (Box plots show min, 25th percentile, median, 75th percentile, max). Markers with prevalence >50% are shown
Microbe/marker N 25th percentile Median 75th percentile LOD (%)
qPCR
 Alternaria alternata 397 0 0 16.5 284 (71.5)
 Aspergillus versicolor 397 0 0 0 351 (88.4)
 Cladosporium 
cladosporioides
397 3.3 7.7 22 1 (0.25)
 Cladosporium herbarum 397 0.4 1 2.7 4 (1.0)
 Cladosporium 
sphaerospermum
397 0.0 0.7 2.2 125 (31.5)
 Group of Pen/Asp 397 140.5 458.5 1784.5 0 (0)
 Trichoderma viride 
group
397 0 0 0.1 256 (64.5)
 Mycobacterium spp. 394 204.4 454.9 945.6 0 (0)
 Streptomyces spp. 397 2.1 5.2 12.7 8 (2.0)
Cell wall markers
 Muramic acid (ng/mg) 394 22.8 34.5 58.2 16 (4.1%)
 LPS (nmol/mg) 391 0.02 0.03 0.05 30 (7.7%)
 Ergosterol (ng/mg) 397 0.49 1.11 1.72 56 (14.1%)
LOD, lower limit of detection.
TABLE  2 Descriptive statistics of 
microbial groups measured by qPCR (cells/
mg dust) and of cell wall markers
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ergosterol) to the regression model did not change the association of 
muramic acid with asthma (data not shown). Gram- negative bacterial 
LPS showed a non- significant inverse association with asthma status (P 
for trend test .10), but not with asthma symptom score (Table 5), and 
a borderline significant inverse association on BHR (trend test P = .06; 
Table 4). In an exploratory, post hoc analysis, we also created a score 
based on LPS and muramic acid, a “total bacterial content” variable. We 
observed significant inverse associations in the highest quartiles with 
asthma (OR [95% CI] for second to forth quartiles: II 1.15 [0.64- 2.05], 
III 0.50 [0.25- 1.01], IV 0.51 [0.27- 0.99]; P for trend test <.01) and for 
atopy II (1.49 [0.53- 4.14], III 1.13 [0.37- 3.45], IV 0.26 [0.08- 0.87]; P 
for trend test .04). Associations with BHR slope were significant in the 
third quartile (0.89 [0.05- 1.72]; P for trend test .07). Higher “total mi-
crobial content” showed an inverse dose- response trend with asthma, 
asthma score, and BHR slope, but findings did not reach statistical sig-
nificance. Analyses of these associations by geographic region revealed 
that the inverse association of muramic acid on asthma status was sta-
tistically significant only in northern Europe (Figure 2, Tables S2-S4).
Measurements of more specific fungal and bacterial taxa using 
qPCR were negatively associated with asthma status for Cladosporium 
species and Streptomyces spp. in the whole population, whereas 
A. versicolor and group of Penicillium/Aspergillus/Paecilomyces variotii 
tended to positively associated with asthma (Table 4). Elevated lev-
els of the bacterial genus Mycobacterium were significantly inversely 
associated with asthma status (middle group; P for trend test .12), 
but showed a significant positive association with BHR slope and 
a trend for higher asthma symptom score (Tables 4 and 5). Overall, 
no statistically significant associations were found between the 
asthma score and microbial genera, species, or groups determined 
with qPCR (Table 5). Analyses by region showed inverse trend for 
Mycobacterium spp. in southern Europe (Figure 2), and an inverse 
association with BHR slope in southern and northern Europe (Figure 
S1). Streptomyces spp. was inversely associated with asthma status 
in northern Europe (Figure 2). Analyses of microbial markers versus 
asthma were also performed adjusted for pet keeping and dampness 
in homes, but those adjustments did not change our observations 
(data not shown).
Only 1 interaction between microbial marker and area, muramic 
acid, reached a P- value below 0.2 (P = .11 unadjusted; P = .17 adjusted 
for parental allergy, smoking status, household density, sex, age, cen-
ter, and area; data not shown).
3.2 | Microbial parameters and atopy
For atopy, both protective and risk associations with microbial pa-
rameters were observed. Significant protective associations in the 
whole population were mostly seen for the general bacterial cell wall 
markers muramic acid (trend test P = .02) and LPS (highest category) 
and C. cladosporioides (trend test P = .04). Risk associations were ob-
served with some fungal exposures and findings were significant for 
Trichoderma viride (trend test P = .03). The risk associations of fungal 
parameters were most pronounced in northern Europe (significant risk 
for ergosterol and T. viride), and the protective qualities of bacterial 
cell wall agents and total microbial exposure on atopy were more pro-
nounced in northern and southern Europe (Figure 2).
4  | DISCUSSION
In this case- control study on prevalent asthma within the adult pop-
ulation of ECRHS II, we found inverse associations of higher levels 
of mainly the bacterial markers in North Europe with asthma status, 
asthma symptom score, and measured BHR, as well as with atopy. 
Overall, significant observations were little consistent between differ-
ent regions in Europe and between the different outcomes assessed, 
but the findings were most consistent for muramic acid, and a similar 
TABLE  3 Correlations between microbial markers
Aaltr Avers Cclad Cherb Cspha PenAsp Tviri Myco Strep MuAc LPS Ergo
Alternaria alternata 1




Cladosporium herbarum 0.42c −0.01 0.72c 1
Cladosporium 
sphaerospermum
0.18c 0.26c 0.21c 0.01 1
Pen/Asp group 0.20c 0.32c 0.22c 0.20c 0.31c 1
Trichoderma viride group 0.22c 0.16b 0.24c 0.17c 0.23c 0.23c 1
Mycobacterium spp. 0.15b 0.07 0.37c 0.32c 0.19 0.12a 0.24c 1
Streptomyces spp. 0.33c 0.10a 0.58c 0.48c 0.22c 0.33c 0.34c 0.40c 1
Muramic acid 0.17c 0.01 −0.01 −0.01 0.11a 0.16b 0.12a −0.00 0.02 1
LPS 0.03 0.00 0.16b 0.17c 0.06 0.03 0.04 0.16b 0.04 0.12a 1
Ergosterol 0.13a 0.17c 0.12a 0.04 0.06 0.22c −0.03 −0.01 0.07 0.12a −0.18c 1
Spearman correlation coefficients. aSignificant at the 0.05 level, bSignificant at the 0.01 level, cSignificant at the 0.001 level.
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TABLE  4 Adjusted associations of mattress dust concentrations of microbial markers on asthma, atopy, and weighted bronchial hyper- 
responsiveness (BHR) slope (negative regression coefficient in BHR slope indicates risk association with the exposure)
Marker
Asthma BHR slope Atopy











Microbial species with strong outdoor contexta
 Alternaria alternatab
 I 0 280 1 .87 191 0 .77 252 1 .22
 II 0.1- 40.3 53 0.69 (0.35- 1.34) 40 −0.27 (−1.03- 0.50) 49 0.56 (0.19- 1.67)
 III >40.3 55 1.03 (0.52- 2.04) 40 −0.07 (−0.95- 0.81) 50 0.54 (0.18- 1.62)
 Cladosporium cladosporioidesb
 I <3.3 99 1 .09 70 0 .57 92 1 .04
 II 3.3- 7.6 97 1.02 (0.56- 1.86) 70 0.11 (−0.71- 0.94) 84 1.12 (0.35- 3.54)
 III 7.7- 22.0 97 1.15 (0.61- 2.15) 63 −0.86 (−1.66- 0.06) 87 0.78 (0.30- 2.03)
 IV >22.0 95 0.52 (0.27- 1.02) 68 −0.09 (−1.06- 0.89) 88 0.43 (0.16- 1.14)
 Cladosporium herbarumb
 I <0.4 100 1 .22 70 0 .93 87 1 .11
 II 0.4- 1.0 96 0.75 (0.41- 1.37) 72 −0.36 (−1.07- 0.35) 89 1.67 (0.63- 4.44)
 III 1.1- 2.7 97 0.68 (0.36- 1.30) 66 −0.04 (−0.87- 0.80) 92 0.91 (0.34- 2.44)
 IV >2.7 95 0.66 (0.33- 1.29) 63 −0.04 (−1.01- 0.93) 83 0.52 (0.18- 1.46)
 Cladosporium sphaerospermumb
 I 0 120 1 .73 83 0 .53 112 1 .69
 II 0.1- 0.7 75 0.42 (0.21- 0.83) 56 0.43 (−0.43- 1.29) 67 0.50 (0.13- 1.89)
 III 0.8- 2.2 99 1.10 (0.57- 2.12) 69 0.10 (−0.88- 1.08) 89 1.17 (0.33- 4.10)
 IV >2.2 94 0.63 (0.32- 1.24) 63 0.42 (−0.49- 1.32) 83 0.91 (0.25- 3.37)
Microbial species/genera/groups related to moisture damagea
 Aspergillus versicolorb
 I 0 344 1 .63 235 0 0.89 312 1 .20
 II 0.1- 159.9 22 0.64 (0.26- 1.61) 18 0.11 (−0.88- 1.09) 19 1.43 (0.29- 3.76)
 III >159.9 22 1.60 (0.63- 4.06) 18 0.03 (−1.20- 1.26) 20 3.02 
(0.70- 13.08)
 Mycobacterium sppb
 I <204.4 98 1 .12 70 0 0.01 89 1 .80
 II 204.4- 454.8 96 0.65 (0.36- 1.18) 70 −0.29 (−1.01- 0.47) 86 0.72 (0.29- 1.79)
 III 454.9- 945.6 95 0.51 (0.28- 0.94) 63 −0.92 (−1.60- 0.23) 89 0.76 (0.29- 2.02)
 IV >945.6 96 0.65 (0.35- 1.19) 67 −0.90 (−1.68- 0.12) 87 0.85 (0.32- 2.21)
 Pen/Asp groupb
 I <140.4 98 1 .57 69 0 0.74 87 1 .65
 II 140.5- 458.5 99 1.31 (0.72- 2.38) 71 −0.84 (−1.56- 0.12) 93 1.95 (0.75- 5.11)
 III 458.6- 1784.5 97 1.24 (0.66- 2.33) 61 −0.35 (−1.23- 0.53) 89 0.57 (0.22- 1.49)
 IV >1784.5 94 1.25 (0.66- 2.37) 70 0.002 (−0.77- 0.78) 82 1.12 (0.38- 3.30)
 T. viride groupb
 I 0 250 1 .85 174 0 0.55 229 1 .03
 II 0.1- 0.2 69 0.86 (0.49- 1.49) 52 −0.02 (−0.65- 0.62) 60 1.68 (0.63- 4.49)
III >0.2 69 0.99 (0.56- 1.76) 45 0.27 (−0.53- 1.06) 62 3.01 (1.12- 8.05)
(Continues)
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trend was noticeable for lipopolysaccharide of Gram- negative bacte-
ria in central and southern Europe. We observe that Gram- positive 
bacteria showed protective associations predominantly in northern 
countries, where microbial exposures were generally lower. Most 
of the fungal parameters were not statistically significantly associ-
ated with health outcomes, although some trends with risk of asthma 
were seen with A. versicolor and group of Penicillium/Aspergillus/
Paecilomyces variotii.
Muramic acid is a major structural component of the peptidoglycan 
layer in the cell wall of Gram- positive bacteria and is thus considered 
a marker of predominantly Gram- positive bacteria, although it does 
occur also to a smaller extent in cell walls of Gram- negative bacteria. 
Studies have shown that peptidoglycan activates the innate immune 
response via Toll- like receptor 2 (TLR- 2) and has immunomodulatory 
qualities.32-36 Some previous studies in children have mainly reported 
protective associations of higher muramic acid levels with wheezing 
and asthma. Muramic acid in mattress dust has been associated with 
lower prevalence of wheezing and asthma in a population of farming 
and non- farming school- aged children in Europe independently of 
farming status or endotoxin levels in the dust samples.37 This same 
Marker
Asthma BHR slope Atopy












 I < 2.1 99 1 .15 68 0 0.85 91 1 .36
 II 2.1- 5.2 96 1.26 (0.70- 2.28) 69 0.09 (−0.73- 0.90) 85 1.06 (0.40- 2.79)
 III 5.3- 12.7 97 0.95 (0.52- 1.74) 61 0.16 (−0.60- 0.91) 85 1.91 (0.73- 5.04)
 IV >12.7 96 0.66 (0.35- 1.26) 73 −0.09 (−0.96- 0.78) 90 1.35 (0.52- 3.51)
Markers of bacterial, fungal, and total microbial content
 Muramic acidc
 I < 2.3 96 1 .07 69 0 0.51 89 1 .02
 II 2.3- 3.4 98 0.71 (0.39- 1.30) 64 −0.27 (−0.98- 0.45) 92 1.73 (0.66- 4.54)
 III 3.5- 5.8 95 0.44 (0.23- 0.82) 69 −0.45 (−1.26- 0.36) 81 0.51 (0.18- 1.45)
 IV >5.8 96 0.60 (0.31- 1.18) 67 0.41 (−0.34- 1.16) 86 0.38 (0.12- 1.17)
 LPS (10- 16)d
 I <0.02 99 1 .10 69 0 0.06 88 1 .12
 II 0.02- 0.03 92 0.77 (0.43- 1.38) 67 0.35 (−0.43- 1.14) 83 0.79 (0.29- 2.13)
 III 0.04- 0.05 95 0.58 (0.32- 1.05) 56 0.55 (−0.35- 1.44) 83 1.04 (0.37- 2.95)
 IV >0.05 96 0.64 (0.35- 1.20) 74 0.83 (−0.06- 1.72) 91 0.33 (0.10- 1.04)
 Ergosterole
 I < 493 98 1 .42 71 0 0.53 89 1 .58
 II 493- 1113 98 1.58 (0.85- 2.94) 64 −0.66 (−1.50- 0.18) 87 1.25 (0.45- 3.48)
 III 1114- 1715 96 1.20 (0.64- 2.26) 62 0.07 (−0.85- 0.99) 86 1.16 (0.38- 3.52)
 IV >1715 96 1.37 (0.72- 2.63) 74 0.28 (−0.63- 1.20) 89 1.39 (0.45- 4.27)
 Total microbial content
 I <3 65 1 .10 45 0 0.19 61 1 .17
 II 4- 5 110 1.04 (0.54- 2.00) 69 −0.14 (−1.02- 0.74) 98 1.55 (0.52- 4.60)
 III 6 43 0.93 (0.41- 2.12) 31 −0.16 (−1.48- 1.16) 39 1.21 (0.27- 5.49)
 IV 7- 8 102 0.67 (0.34- 1.32) 74 0.29 (−0.59- 1.18) 88 0.76 (0.24- 2.40)
 V >8 62 0.56 (0.26- 1.23) 47 0.63 (−0.37- 1.63) 59 0.34 (0.09- 1.25)
Adjusted for parental allergy, smoking status, household density, gender, age, and center. Analyses for atopy and BHR slope were weighted. Markers were 
classified into 4 classes: I = 0- 25 percentile, II = 25- 50, III = 50- 75, IV = 75- 100 or into 3 classes, if there were many below detection limit values: I = 0 
(below detection limit), II = below median, III = above median. For Cladosporium sphaerospermum, the first class is below detection limit. Associations with 
P < .05 are in bold.
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study did not find associations of muramic acid with atopy. Similarly, 
muramic acid levels in bed dust, but not floor dust collected in chil-
dren’s homes (at age 7) in the Boston metropolitan area, were inversely 
associated with current asthma, but not with allergic sensitization.8 
Weber et al38 reported inverse associations of muramic acid load in 
floor, but not mattress dust with asthma in school- aged children in a 
cross- sectional analysis of a German birth cohort.
To our knowledge, there is only 1 comparable study which investi-
gated the associations between microbial exposures measured in the 
home environment with respiratory disorders in adults. A recent study 
that had its population also drawn from the ECRHS II cohort reported 
an association of higher levels of muramic acid in mattress dust with 
the asthma symptom score,39 an effect opposite to the current find-
ings. Tischer et al utilized a population of 956 subjects in 22 centers 
from 10 countries, whereas our current study analyzed 397 study sub-
jects from 14 centers located in 7 countries in an asthma case- control 
design; the 2 study populations did not overlap as concerns the study 
participants. The differences between the 2 studies with respect to the 
participating centers concerned mostly central and southern Europe. 
Approximately 5% of the study population used in the earlier analyses 
had an asthma symptom score of 3 or more and 64% had a score of 
TABLE  5 Associations of log- transformed microbial 
concentrations with asthma score tested using negative binomial 
regression analysis. Ratios were exponentially back transformed
 
Asthma score 
mean ratio 95% CI P- value
Alternaria alternata 0.98 (0.82- 1.18) .85
Cladosporium 
cladosporiodes
1.00 (0.85- 1.17) .97
Cladosporium herbarumz 0.95 (0.83- 1.09) .49
Cladosporium 
sphaerospermum
0.96 (0.84- 1.08) .48
Mycobacteria spp. 1.10 (0.96- 1.26) .17
Group of Pen/Asp 0.92 (0.82- 1.04) .20
Streptomyces spp. 1.03 (0.87- 1.22) .76
T. viride group 0.98 (0.95- 1.02) .38
Ergosterol 0.95 (0.86- 1.05) .30
Muramic acid 0.88 (0.78- 1.01) .06
LPS 10- 16 1.02 (0.89- 1.17) .73
Total microbial content 0.88 (0.77- 1.02) .09
Estimates calculated for an interquartile change. Adjusted for case, paren-
tal allergy, smoking status, household density, gender, age, and center.
F IGURE  2 Associations of microbial markers with asthma and atopy by geographic region (South, Central, North Europe). Adjusted for 
parental allergy, smoking status, household density, gender, age, and center. aOR’s estimated for 1 interquartile change in the microbial marker. 
For atopy, analyses are weighted
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zero, whereas in our current study, it was 21% of the study subjects 
with a score of equal or higher 3 and 50% (the controls) with a score 
of zero. In the earlier study, condensation on the bedroom windows 
and wet or damp spots in the home were frequently observed (>20%), 
and water damage and damp patches increased muramic acid concen-
trations. In our current study, prevalence of wet or damp spots in the 
last 12 months was 21%, but we did not observe correlations between 
dampness indicators and muramic acid levels (data not shown). These 
marked differences in the 2 study populations may well explain the 
diverging findings of the associations between muramic acid and the 
asthma symptom score, in particular given that we observe a depen-
dency of the association by geographic region, with effects being pro-
nounced in the northern European countries. Differences in factors 
that were adjusted for in respective statistical analyses may have also 
added to this observation.
A major source of bacteria indoors is known to be human related 
and this is particularly true when considering mattress dust as a sam-
ple material for analyses of indoor microbiota.40 Human skin is rich 
of Gram- positive bacteria of the Actinobacteria and Firmicutes phyla, 
and skin and other material of human origin are likely to be the major 
source of the Gram- positive bacteria and thus muramic acid in our 
study as well. However, significantly elevated concentrations of mu-
ramic acid have been found from farm children’s mattress dust com-
pared to non- farmers,37 which indicates that environmental sources 
are well reflected also in mattress dust. Sordillo et al41 found that fre-
quent bedroom cleaning and season of sampling had significant im-
pacts on muramic acid levels in a cohort of Boston metropolitan area 
homes. Tischer et al39 found water damage, pets allowed in the bed-
room, current smoking, season, and latitude to be significantly associ-
ated with the mattress dust muramic acid content.39 It is evident that 
mattress dust does reflect not only human- derived but also environ-
mental sources and that the associations found in our study may relate 
to differences in environmental microbial exposure in the study homes.
A study carried out in homes of Finnish and Russian Karelia, 2 
areas in very close geographic vicinity with high similarity in vegetative 
and climatic conditions found a striking overrepresentation of Gram- 
positive bacterial content in dust collected in Russian Karelian homes.42 
Main differences based on DNA sequencing were attributable to bac-
terial sequences of the Staphylococcaceae and Corynebacteriaceae. The 
authors suggested a dominance of animal- associated bacterial spe-
cies in dust from Russian Karelia due to a more emphasized contact 
between humans and animals (livestock and pets), opposed by more 
vegetation- associated species found in the Finnish homes, and also 
linking to difference in prevalence of allergic symptoms and diseases.43 
In our current study, we need to rely on interpreting findings based on 
muramic acid as a general marker for Gram- positive bacteria without 
further resolution and ability to reflect animal, human, or vegetation as 
sources. We can only hypothesize that similar lifestyle factors relating 
to closer animal contact may explain the findings in our study.
Avoidance behavior due to respiratory health problems or allergy, 
that is, increased cleanliness and hygiene measures being implemented 
in homes of asthmatics could provide another explanation for our ob-
servations. Cleaning habits have been shown to affect the muramic 
acid content in mattress dust in a study in the US.41 A German study, 
however, found no association between a home cleanliness score and 
a personal cleanliness score with load or concentration of muramic 
acid in mattress and floor dust samples, while amounts of dust were 
indeed reduced by increased cleanliness measures.38
It is well known that exposure to microbes provides immune stim-
ulus or challenge, which probably protects from developing asthma or 
allergic diseases.5 This could explain the protective effects of bacterial 
agents in mattress dust we see in our study. The protective quality of 
microbial exposure is generally believed to be relevant in early child-
hood, whereas we were investigating an adult population in this study. 
One could speculate that avoidance of animal contact by our asthmatic 
subjects would explain in the lower home dust Gram- positive bacterial 
levels. This was not, however, the case; a similar effect of low animal 
contact also on levels of Gram- negative bacterial LPS would be ex-
pected, which at least in the analysis by geographic region was not ob-
served. Also, the fact that adding other general microbial markers (LPS 
and ergosterol) in the same model with muramic acid did not change the 
protective associations with asthma status indicates that general clean-
liness measures may not be the driving factor underlying the lower mu-
ramic acid levels in the homes of the asthmatics. Assumption on lifetime 
exposure to indoor microbes is difficult or impossible to make based 
on a cross- sectional study as the current, with exposure and health as-
sessment being performed later in life. In summary, the factors underly-
ing and mechanisms explaining the observed inverse relation between 
Gram- positive bacterial levels in mattress dust and asthma and atopy 
cannot be explained based on our current analyses. These are issues 
that will remain to be answered in future, longitudinal studies.
The prevalence and levels of the detected microbial parame-
ters varied largely between different study centers and areas across 
Europe. Tischer et al39 have observed that latitude has a significant 
effect on a number of microbial parameters: increasing latitude in-
creased C. herbarum levels and decreased group of Penicillium/
Aspergillus/Paecilomyces variotii and muramic acid levels. Large geo-
graphic variation of microbial markers has been reported earlier in a 
larger sample of the ECRHS II with endotoxin.44 In our study, the con-
centration of muramic acid in mattress dust was found to be lowest 
in northern Europe, where at the same time the protective effect of 
elevated levels on both respiratory health and atopy was strongest. An 
earlier ECRHS study detected very low exposures to allergens, molds, 
and bacteria especially in Reykjavik, where also the allergic sensitizing 
was lowest.45 The observations of a protective association of elevated 
microbial levels, especially in an area of generally lower exposure, are 
certainly intriguing and should motivate future research efforts.
Exposure to fungal markers increased, mostly non- significantly, 
the risk of respiratory outcomes and atopy in our study, with the ex-
ception of Cladosporium species. The latter, mostly outdoor air- related 
species, showed a trend toward protective associations at higher lev-
els. Correlations between microbial parameters were generally poor 
to moderate, but revealed 2 distinct clusters including microbial pa-
rameters that may represent similar sources. The first group of mark-
ers included A. alternata, C. cladosporioides, C. herbarum, Streptomyces 
spp., Mycobacterium spp., and LPS. These parameters probably are 
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strongly determined by outdoor sources and members of this group 
were mostly inversely associated with respiratory health and atopy, in-
dicating that exposure to microbes from outdoor sources could repre-
sent a rather protective scenario. It is also possible that the increased 
presence of outdoor- derived microbes indicates more efficient re-
placement of indoor pollutants with potential health implications by 
outdoor air. The second group centering around Penicillium/Aspergillus/
Paecilomyces variotii included significant correlations between 0.22 
and 0.32 with A. versicolor, C. sphaerospermum, and ergosterol that 
may be linked mainly to building or indoor sources. The fungal species 
A. versicolor and Trichoderma viride and the fungal group of Penicillium/
Aspergillus/Paecilomyces variotii showed mostly non- significant trends 
to risk association with asthma and/or atopy. These fungal groups are 
generally known to be associated with indoor dampness,46 and expo-
sure to these species has been associated previously with asthma.47,48 
A multitude of studies has shown associations of observed indoor 
dampness and visible mold with respiratory symptoms.1,3,4,49 Also in 
earlier studies of the ECRHS, visible mold or damp patches assessed 
with questionnaire have been associated with increased prevalence 
of asthma symptoms, diagnosed asthma, lung function, and BHR.15,50 
A discrepancy between relationships of observed versus measured 
molds with respiratory health has been repeatedly acknowledged.4,51
In this current study, levels of microbial concentrations were gen-
erally low, especially those analyzed with qPCR. The DNA extraction 
method used in this case- control study involved powerful cleaning 
steps to overcome issues with PCR inhibitors, which explains the gen-
erally low levels reported based on the qPCR analyses. The DNA ex-
traction procedures have been upgraded and changed in the analyzing 
laboratory, which is confirmed by the generally higher levels of some 
of the same qPCR markers in a recently reported study within the 
ECRHS II cohort.39 However, our analyses included the use of internal 
standard, both in the DNA- based qPCRs as well as in the chemical an-
alytical analyses of cell wall agents, taking into account inhibition and 
analyte losses during the laboratory process. Thus, while the absolute, 
microbial levels determined in this study might not be well comparable 
to other, more recent studies that used improved DNA extraction ap-
proaches, the results are robust within the current study and compara-
ble between subjects. Especially fungal material was present in rather 
small amounts in mattress dust, which is supported by the finding that 
ergosterol, which is a general fungal marker and integral part of the 
fungal cell wall, was below detection limit in 12% of the samples.
In conclusion, this is a large cross- sectional asthma case- control 
study among adults across Europe that highlights the potential protec-
tive associations of bacteria and in particular of Gram- positive bacteria 
in mattress dust with asthma and atopy. Our findings indicate that a 
protective effect of higher microbial exposure in an adult population 
may be modified by geographic region and may occur especially in re-
gions where general microbial levels are lower.
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